Bubblr (BBLR) 10-Q 23 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 19, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	333-260902
Entity Registrant Name	Bubblr, Inc.
Entity Central Index Key	0001873722
Entity Tax Identification Number	86-2355916
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	21 West 46th Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	647
Local Phone Number	646 2263
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		141,146,345

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 93,492	$ 62,967
Accounts receivable	14,506	17,966
Advances receivable	78,375	80,251
Total current assets	186,373	161,184
Non-current Assets:
Property and equipment, net	63,400	69,620
Intangible assets, net	1,492,077	1,627,010
Total non-current assets	1,555,477	1,696,630
TOTAL ASSETS	1,741,850	1,857,814
Current Liabilities:
Accounts payable	194,321	200,666
Dividends payable	3,272
Accrued interest	33,295	21,415
Promissory note payable	20,000
Loan payable, current portion	13,015	13,400
Loan payable - related party	461,882	509,339
Total current liabilities	725,785	744,820
Non-current liabilities:
Convertible note payable - net of discount $52,285 and $69,714	2,235,495	2,218,066
Loan payable,  non-current portion	19,245	22,518
Warrant derivative liability	444,891
Total non-current liabilities	2,699,631	2,240,584
Total Liabilities	3,425,416	2,985,404
Stockholders' Deficit
Common stock, $0.01 par value, 3,000,000,000 shares authorized; 141,146,345 and 140,186,096 shares issued and outstanding at March 31, 2022 and December 31, 2021	1,411,464	1,401,861
Additional paid-in capital	5,933,451	5,478,801
Accumulated deficit	(9,419,099)	(8,385,496)
Accumulated other comprehensive income	390,617	377,244
Total Stockholders' Deficit	(1,683,566)	(1,127,590)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,741,850	$ 1,857,814

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument, Unamortized Discount (Premium), Net	$ 52,285	$ 69,714
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	3,000,000,000	3,000,000,000
Common Stock, Shares, Outstanding	141,146,345	140,186,096
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1	1
Preferred stock, shares issued	1	0
Preferred stock, shares outstanding	1	0
Preferred Stock, Value, Issued
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000	2,000
Preferred stock, shares issued	503	0
Preferred stock, shares outstanding	503	0
Preferred Stock, Value, Issued	$ 1

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Expenses
General and administrative	$ 11,119	$ 73,103
Professional fees	192,829	795,146
Market and regulation costs	37,593	13,331
Compensation	140,944	168,963
Amortization and depreciation	107,595	94,844
Research and development	61,261	127,589
Total operating expense	551,341	1,272,976
Operating loss	(551,341)	(1,272,976)
Other income (expense)
Interest income	452	166
Interest expense	(414,844)	(4,800)
Loss on fair value of warrant derivative liability	(23,891)
Foreign currency transaction loss	(40,707)	(6,665)
Total other income (expense)	(478,990)	(11,299)
Net loss before income tax	(1,030,331)	(1,284,275)
Provision for income tax
Net loss after income tax	(1,030,331)	(1,284,275)
Other comprehensive income (loss)
Foreign currency translation gain	13,373	21,008
Total other comprehensive income (loss)	13,373	21,008
Net comprehensive loss	$ (1,016,958)	$ (1,263,267)
Net loss per common share, basic and diluted	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding, basic and diluted	140,499,144	127,025,260

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member]Series A Preferred Stock [Member]	Preferred Stock [Member]Series B Preferred Stock [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Comprehensive Income [Member]	Treasury Stock [Member]	Total
Balance - December 31, 2021 at Dec. 31, 2020				$ 1,325,652	$ 3,704,045	$ (4,692,009)	$ 354,093	$ (60,000)	$ 631,781
Shares, Issued at Dec. 31, 2020	1	2		132,565,226
Preferred B shares conversion to common stock				$ 27	5,973				6,000
[custom:PreferredBSharesConvertedToCommonSharesShares]		(2)		2,650
Issuance of Special 2019 Series A Preferred Stock from Treasury to related party in satisfaction of debt								60,000	60,000
Stock Issued During Period, Shares, Treasury Stock Reissued
Issuance of common shares for Services - Advisory Board				$ 3,061	701,015				704,076
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture				306,120
Issuance of common shares for Services - Consulting				$ 240	59,760				60,000
Stock Issued During Period, Shares, Issued for Services				24,000
Net loss						(1,284,275)			(1,284,275)
Other comprehensive income							21,008		21,008
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Stock Issued During Period, Shares, New Issues			503
Balance -March 31, 2022 at Mar. 31, 2021				$ 1,328,980	4,470,793	(5,976,284)	375,101		198,590
Shares, Issued at Mar. 31, 2021	1			132,897,996
Balance - December 31, 2021 at Dec. 31, 2021				$ 1,401,861	5,478,801	(8,385,496)	377,244		(1,127,590)
Shares, Issued at Dec. 31, 2021	1			140,186,096
Preferred B shares conversion to common stock
Issuance of common shares for Services - Advisory Board				$ 1,480	73,980				75,460
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture				147,960
Issuance of common shares for Services - Consulting				$ 193	8,787				8,980
Stock Issued During Period, Shares, Issued for Services				19,250
Net loss						(1,030,331)			(1,030,331)
Other comprehensive income							13,373		13,373
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Issuance of common shares for Equity Finance Agreement Incentive				$ 7,930	371,884				379,814
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]				793,039
Issuance of Series C Preferred Stock			$ 1		(1)
Stock Issued During Period, Shares, New Issues			503
Dividend Series C Preferred Stock						(3,272)			(3,272)
Preferred Stock Dividends, Shares
Balance -March 31, 2022 at Mar. 31, 2022			$ 1	$ 1,411,464	$ 5,933,451	$ (9,419,099)	$ 390,617		$ (1,683,566)
Shares, Issued at Mar. 31, 2022	1		503	141,146,345

Consolidated Statements of Cash

Consolidated Statements of Cashflows - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (1,033,603)	$ (1,284,275)
Net loss to net cash used in operating activities:
Stock based compensation	84,440	764,076
Stock based finance incentive	379,814
Loss on fair value of warrant derivative liability	23,891
Amortization of debt discount	22,429
Amortization of intangible asset	101,193	94,844
Depreciation	4,223	2,870
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	2,581	(9,334)
Increase (decrease) in accrued interest	10,985	(8,568)
Increase (decrease) in accounts payable	(3,523)	18,358
Net cash used in operating activities	(407,570)	(422,029)
Cash flows from investing activities
Purchase of intangible assets	(11,684)	(35,673)
Net cash used in investing activities	(11,684)	(35,673)
Cash flows from financing activities
Repayment of loans payable	(3,322)	(2,558)
Repayment of loans payable - related party	(52,556)	(225,060)
Proceeds from loans payable - related party	19,709
Net proceeds from issuance of Series C Preferred stock	421,000
Proceeds from issuance of convertible notes payable	15,000	822,572
Net cash provided by financing activities	399,831	594,954
Effects of exchange rate changes on cash	49,948	6,602
Net Change in Cash	30,525	143,854
Cash - Beginning of Period	62,967	96,602	$ 96,602
Cash - End of Period	93,492	240,456	$ 62,967
Supplemental information:
Cash paid for interest	397,955	4,800
Cash paid for taxes
Non-cash investing and financing activities
Issuance of Special 2019 Series A Preferred Stock from Treasury to related party in satisfaction of debt		60,000
Common stock issued for conversion of Series B Preferred Stock		6,000
Warrant liability	$ 449,043

NOTE 1 - ORGANIZATION, BUSINESS

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY	3 Months Ended
	Mar. 31, 2022
Note 1 - Organization Business And Liquidity
NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY	NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY Organization and Operations On March 26, 2020 Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019, and became a 100% Bubblr, Inc. is a Mobile Application software company that is currently developing its disruptive Internet Search Mechanism and seeking license opportunities for a next-generation solution designed to create an alternative economic model. Going Concern Matters The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $1,016,958 $9,419,099 $539,412 Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. See Note 13 – Subsequent Events. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists a substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. COVID-19 A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position as of at March 31, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to collect accounts receivable and the ability of the Company to continue to provide high quality services to its clients. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities at the date of issuance of these financial statements. These estimates may change, as new events occur, and additional information is obtained.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2022
Note 2 - Significant Accounting Policies
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP . The Company’s fiscal year-end is December 31. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP. Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the three months ended March 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At March 31, 2022, the warrant liabilities balance was $444,891 Stock Based Compensation We follow ASC Topic 718, Compensation–Stock Compensation, Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three months ended March 31, 2022 and 2021, the following outstanding stock was excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2022 2021 (Shares) (Shares) Series C Preferred Stock 1,885,072 — Warrants 1,413,804 — Convertible Notes 2,007,994 2,007,994 Total 5,306,870 2,007,994 Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. March 31, December 31. 2022 2021 Period-end GBP£:US$ exchange rate 1.3139 1.3527 Annual average GBP£:US$ exchange rate 1.3412 1.3767 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Losses on foreign exchange transactions totaling $40,707 $6,665 Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. As of March 31, 2022 and December 31, 2021, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies which are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”) which is charged at 25% of any “taxable diverted profits”. The DPT has had effect since April 1, 2015 and may apply in circumstances including: (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and as a result a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

NOTE 3 _ ACCOUNTS RECEIVABLE

NOTE 3 – ACCOUNTS RECEIVABLE	3 Months Ended
	Mar. 31, 2022
Note 3 Accounts Receivable
NOTE 3 – ACCOUNTS RECEIVABLE	NOTE 3 – ACCOUNTS RECEIVABLE As of March 31, 2022 and December 31, 2021, accounts receivable consisted of the following: March 31, December 31, 2022 2021 Deposit $ 2,411 $ 2,682 UK VAT Receivable 11,895 15,084 Prepayments 200 200 Accounts receivable $ 14,506 $ 17,966 Any nominal change in the deposit value is due to exchange rate fluctuation .

NOTE 4 _ ADVANCES RECEIVABLE

NOTE 4 – ADVANCES RECEIVABLE	3 Months Ended
	Mar. 31, 2022
Note 4 Advances Receivable
NOTE 4 – ADVANCES RECEIVABLE	NOTE 4 – ADVANCES RECEIVABLE As of March 31, 2022 and December 31, 2021, cash advances consisted of the following: March 31, December 31, 2021 2021 Advance principal receivable -G $ 52,414 $ 54,529 Advance principal receivable -J 21,022 21,643 Interest due 4,939 4,079 Total advances receivable $ 78,375 $ 80,251 The advance labelled Advance receivable-G carries an interest rate of 3% Any difference on the Advance principal is due to currency translation.

NOTE 5 - PROPERTY AND EQUIPMENT

NOTE 5 - PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
NOTE 5 - PROPERTY AND EQUIPMENT	NOTE 5 - PROPERTY AND EQUIPMENT As of March 31, 2022 and December 31, 2021, property and equipment consisted of the following: Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2021 $ 63,576 $ 31,500 $ 629 $ 95,705 Additions — — — — Effects of currency translation ( 1,823 ) ( 905 ) ( 18 ) ( 2,746 ) At March 31, 2022 $ 61,753 $ 30,595 $ 611 $ 92,959 Less accumulated depreciation At December 31, 2021 $ 14,092 $ 11,710 $ 283 $ 26,085 Depreciation expense 1,642 2,550 31 4,223 Effects of currency translation ( 405 ) ( 336 ) (8 ) ( 749 ) At March 31, 2022 $ 15,329 $ 13,924 $ 306 $ 29,559 Net book value At March 31, 2022 $ 46,424 $ 16,671 $ 305 $ 63,400 At December 31, 2021 $ 49,484 $ 19,790 $ 346 $ 69,620 During the three months ended March 31, 2022 and 2021, the Company recorded depreciation expense of $4,223 $2,870

NOTE 6 - INTANGIBLE ASSETS

NOTE 6 - INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2022
Note 6 - Intangible Assets
NOTE 6 - INTANGIBLE ASSETS	NOTE 6 - INTANGIBLE ASSETS Patents A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa and New Zealand. A Notice of Approval has also been issued for Canada. The patent is currently pending in the following areas: Australia, European Union, United Kingdom. Patents are reported at cost, less accumulated amortization and accumulated impairment loss. Costs includes expenditure that is directly attributable to the acquisition of the asset. Once a patent is providing economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 years Intellectual Property Intellectual Property capitalizes costs of the Company’s qualifying internal research and developments . 7 years Trademarks The Company has the following trademarks Name Type Class Status Territory Citizens Journalist Word & Mark 9 & 38 registered European Union Citizens Journalist Word 9 & 38 registered United Kingdom BAU Not OK Word 9 & 38 registered United Kingdom Newzmine Word 9 & 38 registered United Kingdom The Company has the following mark on the Supplemental Register in the United States Name Type Class Status Territory Citizens Journalist Word & Mark 9, 38, 41 & 42 registered United States The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the asset will be impaired and charged to expense in the period of impairment. As of March 31, 2022 and December 31, 2021, trademarks consisted of the following: March 31, December 31, 2022 2021 Trademarks: NewzMine TM $ 9,636 $ 9,636 Citizens Journalist™ 24,010 23,193 Effects of currency translation ( 942 ) — $ 32,704 $ 32,829 As of March 31, 2022 and December 31, 2021, intangible assets consisted of the following: Cost Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total At December 31, 2021 $ 151,860 $ 32,829 $ 2,861,906 $ 45,745 $ 3,092,340 Additions 10,867 817 — — 11,684 Effects of currency translation ( 4,357 ) ( 942 ) ( 82,089 ) — ( 87,388 ) At March 31, 2022 $ 158,370 $ 32,704 $ 2,779,817 $ 45,745 $ 3,016,636 Less accumulated amortization At December 31, 2021 $ — $ — $ 1,463,042 $ 2,288 $ 1,465,330 Amortization expense 1,343 — 99,278 572 101,193 Effects of currency translation — — ( 41,964 ) — ( 41,964 ) At March 31, 2022 $ 1,343 $ — $ 1,520,356 $ 2,860 $ 1,524,559 Net book value At March 31, 2022 $ 157,027 $ 32,704 $ 1,259,461 $ 42,885 $ 1,492,077 At December 31, 2021 $ 151,860 $ 32,829 $ 1,398,864 $ 43,457 $ 1,627,010 During the three months ended March 31, 2022 and 2021, the Company purchased $11,684 $35,673 $101,193 $94,844 $0 $0 Three months ended March 31, Patents Intellectual Property Capitalized Acquisition Costs Total 9 months remaining 2022 $ 5,889 $ 134,942 $ 1,716 $ 142,547 2023 7,851 179,923 2,288 190,062 2024 7,851 179,923 2,288 190,062 2025 7,851 179,923 2,288 190,062 2026 7,851 179,923 2,288 190,062 Thereafter 119,734 404,827 32,017 556,578 $ 157,027 $ 1,259,461 $ 42,885 $ 1,459,373

NOTE 7 - CONVERTIBLE NOTES PAYA

NOTE 7 - CONVERTIBLE NOTES PAYABLE	3 Months Ended
	Mar. 31, 2022
Note 7 - Convertible Notes Payable
NOTE 7 - CONVERTIBLE NOTES PAYABLE	NOTE 7 - CONVERTIBLE NOTES PAYABLE In January 2021 the Company commenced an offering for a convertible promissory note. The offering closed June 30, 2021. Funds raised as of June 30, 2021 was $2,112,150 $104,572 $822,572 18 Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes. Interest accrual and debt discount amortization commenced July 1, 2021 upon the closing of the convertible promissory note offering. In November 2021 the Company commenced an offering for a convertible promissory note. The offering closed November 30, 2021. Funds raised as of November 30, 2021 totaled $175,630 18 Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes. Interest accrual commenced December 1, 2021 upon the closing of the convertible promissory note offering. At March 31, 2022 and December 31, 2021, convertible notes consisted of the following March 31, December 31, 2022 2021 Promissory notes - issued in fiscal year 2021 2,287,780 2,278,780 Total convertible notes payable 2,287,780 2,278,780 Less: unamortized debt discount (52,285 ) (69,714 ) Less: current portion of convertible notes — — Long-term convertible notes $ 2,235,495 $ 2,218,066 During the three months ended March 31, 2022 and 2021, the Company recorded $36,413 $0 $22,429 and $0

NOTE 8 _ PROMISSORY NOTE AND LO

NOTE 8 – PROMISSORY NOTE AND LOAN PAYABLE	3 Months Ended
	Mar. 31, 2022
Note 8 Promissory Note And Loan Payable
NOTE 8 – PROMISSORY NOTE AND LOAN PAYABLE	NOTE 8 – PROMISSORY NOTE AND LOAN PAYABLE On February 4, 2022 the Company issued a promissory note for the principal sum of $20,000 25% May 1, 2022 $15,000 The Company has purchased a vehicle under a capital finance arrangement. The term of this loan is 5 years 6.90% $13,015 $13,400 $19,245 $22,518 $3,322 $2,558 At March 31, 2022, future minimum payments under the vehicle loan, are as follows: Total 2022 (nine months remaining in 2022) $ 9,964 2023 13,286 2024 12,668 Thereafter — 35,918 Less: Imputed interest ( 3,658 ) Loan payable 32,260 Loan payable – current 13,015 Loan payable - non-current $ 19,245

NOTE 9 - RELATED PARTY TRANSACT

NOTE 9 - RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
NOTE 9 - RELATED PARTY TRANSACTIONS	NOTE 9 - RELATED PARTY TRANSACTIONS Loans from Related Parties The Company has a loan from our Founder with a balance of $415,895 and $428,177 at March 31, 2022 and December 31, 2021, respectively. The loan is non-interest bearing and repayable on demand. The Company received $0 $0 $0 $66,000 three months ended March 31, 2022 and 2021. Activity on this loan to arrive at the March 31, 2022 and December 31, 2021 balances is as follows: Three Months Ended Year Ended December 31, 2022 2021 Beginning balance $ 428,177 $ 500,915 Effects of currency translation (12,282 ) (6,378 ) Loan Payable 415,895 494,177 Less: conversions into preferred stock — (66,000 ) Ending balance $ 415,895 $ 428,177 At December 31, 2020, the Company had loans from two minority shareholders totaling $297,006 . During the fourth quarter of 2021, the Company received an additional loan from one of these minority shareholders totaling $81,162 . The loan is non-interest bearing and due for repayment on February 28, 2022. Agreement was reached to extend repayment of the loan to April 30, 2022, with no penalties. All outstanding amounts were paid by this date (see Note 13). During the three months ended March 31, 2022 and 2021, the Company received proceeds on these loans of $19,709 and $0 , respectively, and made repayments of $52,556 and $225,060 , respectively. Activity on this loan to arrive at the March 31, 2022 and December 31, 2021 balances is as follows: Three Months Ended Year Ended 2022 2021 Beginning balance $ 81,162 $ 297,006 Effects of currency translation (2,328 ) 6,062 Loan Payable 78,834 303,068 Add: additions 19,709 81,162 Less: repayments (52,556 ) (303,068 ) Ending balance $ 45,987 $ 81,162

NOTE 10 - WARRANT LIABILITY

NOTE 10 - WARRANT LIABILITY	3 Months Ended
	Mar. 31, 2022
Note 10 - Warrant Liability
NOTE 10 - WARRANT LIABILITY	NOTE 10 - WARRANT LIABILITY The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 11) for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instrument should be classified as a liability due to reset provisions and variability in exercise price resulting in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our warrant liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of March 31, 2022. The Black Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black Scholes valuation model. For the period ended March 31, 2022, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows Three Months Ended March 31, 2022 Expected term 2.46 2.50 Expected average volatility 216 220% Expected dividend yield 8.33% Risk-free interest rate 1.50 2.28% The following table summarizes the changes in the warrant liabilities during the period ended March 31, 2022: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2021 $ — Addition of new warrants 421,000 Additional day-one loss 28,043 Change in fair value of warrant liability ( 4,152 ) Warrant liability as of March 31, 2022 $ 444,891

NOTE 11 - STOCKHOLDERS_ EQUITY

NOTE 11 - STOCKHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2022
Note 11 - Stockholders Equity
NOTE 11 - STOCKHOLDERS’ EQUITY	NOTE 11 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 25,000,000 $0.001 Special 2019 Series A Preferred Stock The Company has designated one ( 1 $0.001 On March 12, 2021, the Company amended the designation of the Special 2019 Series A Preferred shares and removed the right of the holder to convert the Special 2019 Series A Preferred share to 500,000,000 shares of common stock of the Company. The holder of the Special 2019 Series A Preferred Stock is entitled to 60% of all votes entitled to vote at each meeting of stockholders of the Corporation (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Corporation for their action or consideration. As of March 31, 2022 and December 31, 2021, the Company had 1 0 Series B Preferred Stock At March 31, 2022 and December 31, 2021, the Company had designated 0 0 $0.001 Prior to the retirement of the Series B Preferred Stock, the following designations were in effect: Holders of the Series B Preferred Stock shall after two years of issuance, convert this Class B Preferred Stock based on each Class B Preferred Share equaling .00001% of the total issued and outstanding Common shares of the Company. In the event of a merger, reorganization, recapitalization or similar event of or with respect to the Corporation (other than a Corporate Change in which the Corporation is the surviving entity), this Class B Preferred Stock shall be converted based on each Class B Preferred Share equaling .00001% of the total issued and outstanding shares of common stock of the Company During 2021, the Company converted the 2 2,650 $6,000 As of March 31, 2022 and December 31, 2021, the Company had 0 0 Series C Convertible Preferred Stock On March 4, 2022, the Company filed a Certificate of Designation with the Wyoming Secretary of State, which established 2,000 $1,200 The Company has the right to redeem the Series C Convertible Preferred Stock, in accordance with the following schedule: · If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days’ of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends. · If all of the Series C Convertible Preferred Stock are redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends · The Company shall pay a dividend of 8% The Series C Convertible Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations (as set forth in the Certificate of Designation). Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock subject to Beneficial Ownership Limitations determined by dividing the Stated Value of $1,200 of such share by the Conversion Price of $0.3202. On March 4, 2022, the Company entered into a Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, in tranches, up to $700,000 700 On March 4, 2022, the Company issued to GHS the first tranche of 300 35 941,599 75% GHS delivered gross proceeds of $266,000.00 On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP (“Proactive”), whereby Proactive agreed to purchase 160 $155,000 The Company agreed to issue Proactive commitment shares of 8 472,205 75% On March 9, the Company issued 168 shares of Series C Convertible Preferred stock to Proactive Capital Partners LP as per the Securities Purchase Agreement. GHS delivered gross proceeds of $290,000.00 As a result of the above transactions, the Company received total net proceeds of $421,000 $449,043 $28,043 503 0 Common Stock The Company has authorized 3,000,000,000 $0.01 Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. During the three months ended March 31, 2022 and 2021, the Company issued common shares as follows: Three months ended March 31, 2021 · 306,120 $704,076 · 24,000 $60,000 · 2,650 $6,000 Three months ended March 31, 2022 · 147,960 $75,460 · 19,250 $8,980 · 587,039 · 206,000 · 503 75% As at March 31, 2022 and December 31, 2021, the Company had 141,146,345 140,186,096 Warrants The Company identified conversion features embedded within warrants issued during the period ended March 31, 2022. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments in redemption value and number of shares issued upon exercise (see Note 10 Warrant Liability). A summary of activity during the period ended March 31, 2022 follows: Warrants Outstanding Number of Warrants Weighted Average Exercise Price Weighted Average Remaining life (years) Outstanding, December 31, 2021 — $ — — Granted 1,413,804 0.34 5.00 Exercised — — — Forfeited/canceled — — — Outstanding, March 31, 2022 1,413,804 $ 0.34 4.93 Exercisable Warrants, March 31, 2022 1,413,804 $ 0.34 4.93 The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2022: Warrants Outstanding Warrants Exercisable Number of Warrants Weighted Average Remaining Contractual life Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price 941,599 4.93 $ 0.34 941,599 $ 0.34 472,205 4.94 0.34 472,205 0.34 1,413,804 4.93 $ 0.34 1,413,804 $ 0.34 As at March 31, 2022 the intrinsic value of the warrants is $112,539

NOTE 12 - COMMITMENTS AND CONTI

NOTE 12 - COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
Note 12 - Commitments And Contingencies
NOTE 12 - COMMITMENTS AND CONTINGENCIES	NOTE 12 - COMMITMENTS AND CONTINGENCIES During the three months ended March 31, 2022 and 2021, the Company paid $1,969 $3,045 12 12 $600 During the three months ended March 31, 2022 and 2021, the Company paid $600 $0 twelve months $200 The Company has entered into an employment agreement with Steven Saunders, our Chief Commercial Officer and Director. The term is three years commencing July 1, 2021. Mr. Saunders is to receive monthly cash compensation of $15,000 reduced by $3,820 until at least $5,000,000 funding has been received through the S-1 offering. See Note 13 for a detail of employment terms amended subsequent to March 31, 2022. The Company entered into employment agreement with Stephen Morris, our Founder and Chief Technology Officer, the term is three years commencing July 1, 2021. Mr. Morris is to receive monthly cash compensation of $15,000 reduced by $4,790 until at least $5,000,000 has been received through the S-1 offering. The Company has entered into an employment agreement with Rik Willard to act as Chief Executive Officer of the company and as Director. The term is 1 year commencing August 15,2021. Mr. Willard is to receive monthly cash compensation of $15,000 reduced by $3,000 until at least $5,000,000 funding has been received through the S-1 offering. Mr. Willard was also granted a signing bonus of 102,040 restricted shares, which were issued in June 2021. See Note 13 for a detail of employment terms amended subsequent to March 31, 2022. On March 25, 2022, the Company entered into a service agreement with PCG Advisory, Inc. The term is six months $7,000 $7,000

NOTE 13 - SUBSEQUENT EVENTS

NOTE 13 - SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
NOTE 13 - SUBSEQUENT EVENTS	NOTE 13 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date of issuance of these consolidated financial statements and noted the following events requiring disclosure: Employment Agreements On April 20, 2022, our board of directors approved amended and restated employment agreements in favor of our Chief Executive Officer, Rik Willard, and our Chief Commercial Officer, Steven Saunders. Since that time, however, the parties to the transaction, in consultation with tax and other professionals, have tabled formal execution of the agreements to work out specific issues. The board will revisit the compensation arrangements with management, and agreements are expected to be executed and filed as appropriate with the SEC upon completion. GHS Investments, LLC On April 22, 2022, the Company issued a second tranche of 200 562,149 $700,000 700 Related Party Loan In February 2022, agreement was reached with a minority shareholder to extend repayment of the outstanding loan amount received by the Company in the fourth quarter of 2021 of $81,162 $28,613

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2022
Note 2 - Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP . The Company’s fiscal year-end is December 31.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.
Convertible Financial Instruments	Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the three months ended March 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At March 31, 2022, the warrant liabilities balance was $444,891 Stock Based Compensation We follow ASC Topic 718, Compensation–Stock Compensation,
Common Stock Purchase Warrants and Derivative Financial Instruments	Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.
Basic and Diluted Net Loss per Common Share	Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three months ended March 31, 2022 and 2021, the following outstanding stock was excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2022 2021 (Shares) (Shares) Series C Preferred Stock 1,885,072 — Warrants 1,413,804 — Convertible Notes 2,007,994 2,007,994 Total 5,306,870 2,007,994
Foreign Currency Translations	Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. March 31, December 31. 2022 2021 Period-end GBP£:US$ exchange rate 1.3139 1.3527 Annual average GBP£:US$ exchange rate 1.3412 1.3767 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Losses on foreign exchange transactions totaling $40,707 $6,665
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. As of March 31, 2022 and December 31, 2021, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies which are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”) which is charged at 25% of any “taxable diverted profits”. The DPT has had effect since April 1, 2015 and may apply in circumstances including: (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and as a result a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2022
Note 2 - Significant Accounting Policies
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings per Share	March 31, 2022 2021 (Shares) (Shares) Series C Preferred Stock 1,885,072 — Warrants 1,413,804 — Convertible Notes 2,007,994 2,007,994 Total 5,306,870 2,007,994
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Tranlation Adjustments	March 31, December 31. 2022 2021 Period-end GBP£:US$ exchange rate 1.3139 1.3527 Annual average GBP£:US$ exchange rate 1.3412 1.3767

NOTE 3 _ ACCOUNTS RECEIVABLE (T

NOTE 3 – ACCOUNTS RECEIVABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Note 3 Accounts Receivable
NOTE 3 - ACCOUNTS RECEIVABLE	March 31, December 31, 2022 2021 Deposit $ 2,411 $ 2,682 UK VAT Receivable 11,895 15,084 Prepayments 200 200 Accounts receivable $ 14,506 $ 17,966

NOTE 4 _ ADVANCES RECEIVABLE (T

NOTE 4 – ADVANCES RECEIVABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Note 4 Advances Receivable
NOTE 4 - ADVANCES RECEIVABLE - Schedule of Cash Advances	March 31, December 31, 2021 2021 Advance principal receivable -G $ 52,414 $ 54,529 Advance principal receivable -J 21,022 21,643 Interest due 4,939 4,079 Total advances receivable $ 78,375 $ 80,251

NOTE 5 - PROPERTY AND EQUIPME_2

NOTE 5 - PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
NOTE 5 - PROPERTY AND EQUIPMENT - Schedule of Property Pant and Equipment	Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2021 $ 63,576 $ 31,500 $ 629 $ 95,705 Additions — — — — Effects of currency translation ( 1,823 ) ( 905 ) ( 18 ) ( 2,746 ) At March 31, 2022 $ 61,753 $ 30,595 $ 611 $ 92,959 Less accumulated depreciation At December 31, 2021 $ 14,092 $ 11,710 $ 283 $ 26,085 Depreciation expense 1,642 2,550 31 4,223 Effects of currency translation ( 405 ) ( 336 ) (8 ) ( 749 ) At March 31, 2022 $ 15,329 $ 13,924 $ 306 $ 29,559 Net book value At March 31, 2022 $ 46,424 $ 16,671 $ 305 $ 63,400 At December 31, 2021 $ 49,484 $ 19,790 $ 346 $ 69,620

NOTE 6 - INTANGIBLE ASSETS (Tab

NOTE 6 - INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2022
Note 6 - Intangible Assets
NOTE 6 - INTANGIBLE ASSETS - Trademarks	March 31, December 31, 2022 2021 Trademarks: NewzMine TM $ 9,636 $ 9,636 Citizens Journalist™ 24,010 23,193 Effects of currency translation ( 942 ) — $ 32,704 $ 32,829
NOTE 6 - INTANGIBLE ASSETS - Schedule of Intangible Assets	Cost Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total At December 31, 2021 $ 151,860 $ 32,829 $ 2,861,906 $ 45,745 $ 3,092,340 Additions 10,867 817 — — 11,684 Effects of currency translation ( 4,357 ) ( 942 ) ( 82,089 ) — ( 87,388 ) At March 31, 2022 $ 158,370 $ 32,704 $ 2,779,817 $ 45,745 $ 3,016,636 Less accumulated amortization At December 31, 2021 $ — $ — $ 1,463,042 $ 2,288 $ 1,465,330 Amortization expense 1,343 — 99,278 572 101,193 Effects of currency translation — — ( 41,964 ) — ( 41,964 ) At March 31, 2022 $ 1,343 $ — $ 1,520,356 $ 2,860 $ 1,524,559 Net book value At March 31, 2022 $ 157,027 $ 32,704 $ 1,259,461 $ 42,885 $ 1,492,077 At December 31, 2021 $ 151,860 $ 32,829 $ 1,398,864 $ 43,457 $ 1,627,010
NOTE 6 - INTANGIBLE ASSETS - Amortization Expense	Three months ended March 31, Patents Intellectual Property Capitalized Acquisition Costs Total 9 months remaining 2022 $ 5,889 $ 134,942 $ 1,716 $ 142,547 2023 7,851 179,923 2,288 190,062 2024 7,851 179,923 2,288 190,062 2025 7,851 179,923 2,288 190,062 2026 7,851 179,923 2,288 190,062 Thereafter 119,734 404,827 32,017 556,578 $ 157,027 $ 1,259,461 $ 42,885 $ 1,459,373

NOTE 7 - CONVERTIBLE NOTES PA_2

NOTE 7 - CONVERTIBLE NOTES PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Note 7 - Convertible Notes Payable
NOTE 7 - CONVERTIBLE NOTES PAYABLE - Schedule of Convertible Notes Payable	March 31, December 31, 2022 2021 Promissory notes - issued in fiscal year 2021 2,287,780 2,278,780 Total convertible notes payable 2,287,780 2,278,780 Less: unamortized debt discount (52,285 ) (69,714 ) Less: current portion of convertible notes — — Long-term convertible notes $ 2,235,495 $ 2,218,066

NOTE 8 _ PROMISSORY NOTE AND _2

NOTE 8 – PROMISSORY NOTE AND LOAN PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Note 8 Promissory Note And Loan Payable
NOTE 8 - LOANS PAYABLE - Future Minimum Payments	Total 2022 (nine months remaining in 2022) $ 9,964 2023 13,286 2024 12,668 Thereafter — 35,918 Less: Imputed interest ( 3,658 ) Loan payable 32,260 Loan payable – current 13,015 Loan payable - non-current $ 19,245

NOTE 9 - RELATED PARTY TRANSA_2

NOTE 9 - RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
NOTE 9 - RELATED PARTY TRANSACTIONS - Founder Loan	Three Months Ended Year Ended December 31, 2022 2021 Beginning balance $ 428,177 $ 500,915 Effects of currency translation (12,282 ) (6,378 ) Loan Payable 415,895 494,177 Less: conversions into preferred stock — (66,000 ) Ending balance $ 415,895 $ 428,177
NOTE 9 - RELATED PARTY TRANSACTIONS - Shareholder Loans	Three Months Ended Year Ended 2022 2021 Beginning balance $ 81,162 $ 297,006 Effects of currency translation (2,328 ) 6,062 Loan Payable 78,834 303,068 Add: additions 19,709 81,162 Less: repayments (52,556 ) (303,068 ) Ending balance $ 45,987 $ 81,162

NOTE 10 - WARRANT LIABILITY (Ta

NOTE 10 - WARRANT LIABILITY (Tables)	3 Months Ended
	Mar. 31, 2022
Note 10 - Warrant Liability
NOTE 10 - WARRANT LIABILITY - Fair Value of Warrant Liabilities Measured on a Recurring Basis	Three Months Ended March 31, 2022 Expected term 2.46 2.50 Expected average volatility 216 220% Expected dividend yield 8.33% Risk-free interest rate 1.50 2.28%
NOTE 10 - WARRANT LIABILITY - Schedule of Changes in Warrant Liabilities	Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2021 $ — Addition of new warrants 421,000 Additional day-one loss 28,043 Change in fair value of warrant liability ( 4,152 ) Warrant liability as of March 31, 2022 $ 444,891

NOTE 11 - STOCKHOLDERS_ EQUITY

NOTE 11 - STOCKHOLDERS’ EQUITY (Tables)	3 Months Ended
	Mar. 31, 2022
Note 11 - Stockholders Equity
NOTE 11 - STOCKHOLDERS EQUITY - Summary of Warrant Activity	Warrants Outstanding Number of Warrants Weighted Average Exercise Price Weighted Average Remaining life (years) Outstanding, December 31, 2021 — $ — — Granted 1,413,804 0.34 5.00 Exercised — — — Forfeited/canceled — — — Outstanding, March 31, 2022 1,413,804 $ 0.34 4.93 Exercisable Warrants, March 31, 2022 1,413,804 $ 0.34 4.93
NOTE 11 - STOCKHOLDERS EQUITY - Summary of Outstanding Warrants	Warrants Outstanding Warrants Exercisable Number of Warrants Weighted Average Remaining Contractual life Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price 941,599 4.93 $ 0.34 941,599 $ 0.34 472,205 4.94 0.34 472,205 0.34 1,413,804 4.93 $ 0.34 1,413,804 $ 0.34

NOTE 1 - ORGANIZATION, BUSINE_2

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Oct. 22, 2019
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 1,016,958	$ 1,263,267
Retained Earnings (Accumulated Deficit)	9,419,099		$ 8,385,496
[custom:LiabilitiesCurrentInExcessOfAssetsCurrent-0]	$ 539,412
U W R L [Member]
Equity Method Investment, Ownership Percentage				100.00%

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings per Share (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total	5,306,870	2,007,994
Preferred Stock [Member] | Series C Preferred Stock [Member]
Total	1,885,072
Derivative One [Member]
Total	1,413,804
Convertible Notes [Member]
Total	2,007,994	2,007,994

NOTE 2 - SIGNIFICANT ACCOUNTI_5

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Tranlation Adjustments (Details)	Mar. 31, 2022	Dec. 31, 2021
Note 2 - Significant Accounting Policies
Period-end GBP£:US$ exchange rate	1.3139	1.3527
Annual average GBP£:US$ exchange rate	1.3412	1.3767

NOTE 2 - SIGNIFICANT ACCOUNTI_6

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Note 2 - Significant Accounting Policies
Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned, Not Subject to Master Netting Arrangement	$ 444,891
Foreign Currency Transaction Loss, before Tax	$ 40,707	$ 6,665

NOTE 3 - ACCOUNTS RECEIVABLE (D

NOTE 3 - ACCOUNTS RECEIVABLE (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Note 3 Accounts Receivable
Deposit	$ 2,411	$ 2,682
UK VAT Receivable	11,895	15,084
Prepayments	200	200
Accounts receivable	$ 14,506	$ 17,966

NOTE 4 - ADVANCES RECEIVABLE -

NOTE 4 - ADVANCES RECEIVABLE - Schedule of Cash Advances (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Interest due	$ 4,939	$ 4,079
Total advances receivable	78,375	80,251
Advance G W [Member]
Customer Advances, Current	52,414	54,529
Advance J M [Member]
Customer Advances, Current	$ 21,022	$ 21,643

NOTE 4 _ ADVANCES RECEIVABLE (D

NOTE 4 – ADVANCES RECEIVABLE (Details Narrative)	Mar. 31, 2022
Advance G W [Member]
Short-Term Debt, Percentage Bearing Fixed Interest Rate	3.00%

NOTE 5 - PROPERTY AND EQUIPME_3

NOTE 5 - PROPERTY AND EQUIPMENT - Schedule of Property Pant and Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 92,959		$ 95,705
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	49,948	$ 6,602
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	29,559		26,085
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	4,223
Temporary Equity, Foreign Currency Translation Adjustments	749
Property, Plant and Equipment, Net	63,400		69,620
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	61,753		63,576
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	1,823
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	15,329		14,092
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	1,642
Temporary Equity, Foreign Currency Translation Adjustments	405
Property, Plant and Equipment, Net	46,424
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	30,595		31,500
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	905
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	13,924		11,710
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	2,550
Temporary Equity, Foreign Currency Translation Adjustments	336
Property, Plant and Equipment, Net	16,671		19,790
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	611		629
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	18
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	306		283
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	31
Temporary Equity, Foreign Currency Translation Adjustments	(8)
Property, Plant and Equipment, Net	305		346
Total [Member]
Property, Plant and Equipment [Line Items]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	$ 2,746
Automobiles Quarterly [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Net			$ 49,484

NOTE 5 - PROPERTY AND EQUIPME_4

NOTE 5 - PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation	$ 4,223	$ 2,870

NOTE 6 - INTANGIBLE ASSETS - Tr

NOTE 6 - INTANGIBLE ASSETS - Trademarks (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 30, 2020
Indefinite-Lived Trademarks	$ 32,704	$ 32,829
Trademarks [Member]
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	942
Newz Mine [Member]
Indefinite-Lived Trademarks	9,636		$ 9,636
Citizens Journalist [Member]
Indefinite-Lived Trademarks	$ 24,010	$ 23,193

NOTE 6 - INTANGIBLE ASSETS - S

NOTE 6 - INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Finite-Lived Patents, Gross	$ 158,370		$ 151,860
Indefinite-Lived Trademarks	32,704		32,829
Capitalized Costs, Proved Properties	45,745		45,745
Finite-Lived Intangible Assets, Gross	3,016,636		3,092,340
Finite-Lived Intangible Assets, Period Increase (Decrease)	11,684	$ 35,673
Finite-Lived Intangible Assets, Accumulated Amortization	1,524,559		1,465,330
Amortization of Intangible Assets	101,193	$ 94,844
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	41,964
Finite-Lived Intangible Assets, Net	1,492,077		1,627,010
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	87,388
Intellectual Property [Member]
Intangible Assets, Gross (Excluding Goodwill)	2,779,817		2,861,906
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	82,089
Finite-Lived Intangible Assets, Accumulated Amortization	1,520,356		1,463,042
Amortization of Intangible Assets	99,278
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	41,964
Finite-Lived Intangible Assets, Net	1,259,461		1,398,864
Patents [Member]
Finite-Lived Intangible Assets, Period Increase (Decrease)	10,867
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	4,357
Finite-Lived Intangible Assets, Accumulated Amortization	1,343
Amortization of Intangible Assets	1,343
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	157,027		151,860
Trademarks [Member]
Finite-Lived Intangible Assets, Period Increase (Decrease)	817
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	942
Finite-Lived Intangible Assets, Accumulated Amortization
Amortization of Intangible Assets
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	32,704		32,829
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
Finite-Lived Intangible Assets, Accumulated Amortization	2,860		2,288
Amortization of Intangible Assets	572
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	$ 42,885		$ 43,457

NOTE 6 - INTANGIBLE ASSETS - Am

NOTE 6 - INTANGIBLE ASSETS - Amortization Expense (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	$ 142,547
Finite-Lived Intangible Asset, Expected Amortization, Year Two	190,062
Finite-Lived Intangible Asset, Expected Amortization, Year Three	190,062
Finite-Lived Intangible Asset, Expected Amortization, Year Four	190,062
Finite-Lived Intangible Asset, Expected Amortization, Year Five	190,062
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	556,578
Finite-Lived Intangible Assets, Net	1,492,077	$ 1,627,010
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	1,459,373
Patents [Member]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	5,889
Finite-Lived Intangible Asset, Expected Amortization, Year Two	7,851
Finite-Lived Intangible Asset, Expected Amortization, Year Three	7,851
Finite-Lived Intangible Asset, Expected Amortization, Year Four	7,851
Finite-Lived Intangible Asset, Expected Amortization, Year Five	7,851
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	119,734
Finite-Lived Intangible Assets, Net	157,027	151,860
Intellectual Property [Member]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	134,942
Finite-Lived Intangible Asset, Expected Amortization, Year Two	179,923
Finite-Lived Intangible Asset, Expected Amortization, Year Three	179,923
Finite-Lived Intangible Asset, Expected Amortization, Year Four	179,923
Finite-Lived Intangible Asset, Expected Amortization, Year Five	179,923
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	404,827
Finite-Lived Intangible Assets, Net	1,259,461	1,398,864
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	1,259,461
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	1,716
Finite-Lived Intangible Asset, Expected Amortization, Year Two	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Three	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Four	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Five	2,288
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	32,017
Finite-Lived Intangible Assets, Net	42,885	$ 43,457
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	$ 42,885

NOTE 6 - INTANGIBLE ASSETS (Det

NOTE 6 - INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-Lived Intangible Assets, Period Increase (Decrease)	$ 11,684	$ 35,673
Amortization of Intangible Assets	101,193	94,844
Impairment of Intangible Assets, Finite-Lived	$ 0	$ 0
Patents [Member]
Finite-Lived Intangible Asset, Useful Life	20 years
Finite-Lived Intangible Assets, Period Increase (Decrease)	$ 10,867
Amortization of Intangible Assets	$ 1,343
Intellectual Property [Member]
Finite-Lived Intangible Asset, Useful Life	7 years
Finite-Lived Intangible Assets, Period Increase (Decrease)
Amortization of Intangible Assets	$ 99,278

NOTE 7 - CONVERTIBLE NOTES PA_3

NOTE 7 - CONVERTIBLE NOTES PAYABLE - Schedule of Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Schedule of Capitalization, Long-Term Debt [Line Items]
Total convertible notes payable	$ 2,287,780	$ 2,278,780
Less: unamortized debt discount	(52,285)	(69,714)
Less: current portion of convertible notes
Long-term convertible notes	2,235,495	2,218,066
Promissory Notes Issued In Fiscal Year 2021 [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Convertible Debt	$ 2,287,780	$ 2,278,780

NOTE 7 - CONVERTIBLE NOTES PA_4

NOTE 7 - CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 30, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Schedule of Capitalization, Long-Term Debt [Line Items]
Interest Expense		$ 414,844	$ 4,800
Offering [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Proceeds from Notes Payable			822,572	$ 2,112,150
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net				$ 104,572
Debt Instrument, Term		18 months
Debt Instrument, Interest Rate Terms		Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes.
Offering [Member] | Voluntary Conversion [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature		Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Offering [Member] | Mandatory Conversion [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature		Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Nov 2021 Offering [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Proceeds from Notes Payable	$ 175,630
Debt Instrument, Term	18 months
Nov 2021 Offering [Member] | Voluntary Conversion [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature	Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Debt Instrument, Interest Rate Terms	Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes.
Nov 2021 Offering [Member] | Mandatory Conversion [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature	Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Convertible Loans [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Interest Expense		$ 36,413	0
Amortization of Debt Discount (Premium)		$ 22,429	$ 0

NOTE 8 - LOANS PAYABLE - Future

NOTE 8 - LOANS PAYABLE - Future Minimum Payments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Schedule of Capitalization, Long-Term Debt [Line Items]
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year	$ 9,964
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two	13,286
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three	12,668
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four
Loans Payable	32,260
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	3,658
Loans Payable, Current	13,015	$ 13,400
Loans Payable, Noncurrent	19,245	$ 22,518
Future Payments Total [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Loans Payable	$ 35,918

NOTE 8 _ PROMISSORY NOTE AND _3

NOTE 8 – PROMISSORY NOTE AND LOAN PAYABLE (Details Narrative) - USD ($)	Feb. 04, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Schedule of Capitalization, Long-Term Debt [Line Items]
Loans Payable, Current		$ 13,015		$ 13,400
Loans Payable, Noncurrent		19,245		$ 22,518
Payments of Financing Costs		3,322
Payments for Loans		$ 3,322	$ 2,558
White Lion Note [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 20,000
Debt Instrument, Interest Rate, Effective Percentage	25.00%
Debt Instrument, Maturity Date	May 1, 2022
Proceeds from Notes Payable	$ 15,000
Vehicle [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Interest Rate, Effective Percentage		6.90%
Debt Instrument, Term		5 years

NOTE 9 - RELATED PARTY TRANSA_3

NOTE 9 - RELATED PARTY TRANSACTIONS - Founder Loan (Details) - Founder Loan [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	$ 428,177	$ 500,915
Effects of currency translation	(12,282)	(6,378)
Less: conversions into preferred stock		(66,000)
Principal Amount Outstanding of Loans Held-in-portfolio	415,895	428,177
Founder Loan [Member]
Related Party Transaction [Line Items]
Loan Payable	$ 415,895	$ 494,177

NOTE 9 - RELATED PARTY TRANSA_4

NOTE 9 - RELATED PARTY TRANSACTIONS - Shareholder Loans (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule of Capitalization, Long-Term Debt [Line Items]
Add: additions	$ 19,709
Less: repayments	3,322	2,558
Shareholder Loans [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Face Amount	45,987		$ 81,162	$ 297,006
Effects of currency translation	(2,328)		6,062
Loan Payable	78,834		303,068
Add: additions	19,709	0	81,162
Less: repayments	$ (52,556)	$ (225,060)	$ (303,068)

NOTE 9 - RELATED PARTY TRANSA_5

NOTE 9 - RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule of Capitalization, Long-Term Debt [Line Items]
Proceeds from Related Party Debt	$ 19,709
Payments for Loans	3,322	2,558
Payments for Loans	(3,322)	(2,558)
Founder Loan [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Principal Amount Outstanding of Loans Held-in-portfolio	415,895		$ 428,177
Proceeds from Related Party Debt	0	0
Payments for Loans	0	66,000
Debt Instrument, Face Amount	428,177		500,915
Payments for Loans	0	(66,000)
Shareholder Loans [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Proceeds from Related Party Debt	19,709	0	81,162
Payments for Loans	(52,556)	(225,060)	(303,068)
Debt Instrument, Face Amount	45,987		81,162	$ 297,006
Payments for Loans	$ 52,556	$ 225,060	303,068
Shareholder Loans Two [Member]
Schedule of Capitalization, Long-Term Debt [Line Items]
Debt Instrument, Face Amount			$ 81,162

NOTE 10 - WARRANT LIABILITY - F

NOTE 10 - WARRANT LIABILITY - Fair Value of Warrant Liabilities Measured on a Recurring Basis (Details)	3 Months Ended
	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	21600.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	220.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	8.33%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	150.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	2.28%
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	2 years 5 months 15 days
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	2 years 6 months

NOTE 10 - WARRANT LIABILITY - S

NOTE 10 - WARRANT LIABILITY - Schedule of Changes in Warrant Liabilities (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Note 10 - Warrant Liability
Derivative Liability, Subject to Master Netting Arrangement, before Offset	$ 444,891
Increase (Decrease) in Derivative Liabilities	421,000
Derivative, Loss on Derivative	28,043
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	$ 4,152

NOTE 11 - STOCKHOLDERS EQUITY -

NOTE 11 - STOCKHOLDERS EQUITY - Summary of Warrant Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	1,413,804
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 11 months 4 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted	1,413,804
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.34
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageExercisePrice]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share
Warrants Granted [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	5 years
Warrants Exercised [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Warrants Forfeited [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms

NOTE 11 - STOCKHOLDERS EQUITY_2

NOTE 11 - STOCKHOLDERS EQUITY - Summary of Outstanding Warrants (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	1,413,804
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 11 months 4 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
G H S [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	941,599
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 11 months 4 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
Proactive [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	472,205
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 11 months 8 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34

NOTE 11 - STOCKHOLDERS_ EQUIT_2

NOTE 11 - STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	2 Months Ended	3 Months Ended			12 Months Ended
	Mar. 12, 2021	Mar. 31, 2022	Mar. 30, 2022	Mar. 31, 2021	Dec. 31, 2021	Mar. 09, 2022	Mar. 04, 2022
Preferred Stock, Shares Authorized		25,000,000			25,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number		1,413,804
Derivative, Loss on Derivative		$ 28,043
Common Stock, Shares Authorized		3,000,000,000			3,000,000,000
Common Stock, Par or Stated Value Per Share		$ 0.01			$ 0.01
Common Stock, Voting Rights		Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.
Stock Issued During Period, Value, Issued for Services		$ 8,980		$ 60,000
[custom:PreferredBSharesConvertedToCommonSharesValue]				(6,000)
Common Stock, Shares, Issued		141,146,345			140,186,096
Common Stock, Shares, Outstanding		141,146,345			140,186,096
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding		$ 112,539
Founder Loan [Member]
Conversion of Stock, Amount Converted					$ (66,000)
[custom:PreferredBSharesConvertedToCommonSharesValue]				$ 6,000
G H S [Member]
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value							$ 700,000
Preferred Stock, Shares Subscribed but Unissued							700
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number		941,599
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants		$ 266,000
Proactive [Member]
Preferred Stock, Shares Subscribed but Unissued						160
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number		472,205
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants		$ 155,000
Proactive Two [Member]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants		290,000
Proactive Total [Member]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants		421,000
Warrant Allocated [Member]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants		$ 449,043
Advisory Board [Member]
Stock Issued During Period, Shares, Issued for Services		147,960		306,120
Stock Issued During Period, Value, Issued for Services		$ 75,460		$ 704,076
Investor Relations [Member]
Stock Issued During Period, Shares, Issued for Services		19,250		24,000
Stock Issued During Period, Value, Issued for Services		$ 8,980		$ 60,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues
Stock Issued During Period, Shares, Issued for Services		19,250		24,000
Stock Issued During Period, Value, Issued for Services		$ 193		$ 240
[custom:PreferredBSharesConvertedToCommonSharesShares]				2,650
[custom:PreferredBSharesConvertedToCommonSharesValue]				$ (27)
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]		793,039
Commitment Shares To G H S [Member]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]		587,039
Termination Agreement White Lion [Member]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]		206,000
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized		1			1
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001
Preferred Stock, Voting Rights		The holder of the Special 2019 Series A Preferred Stock is entitled to 60% of all votes entitled to vote at each meeting of stockholders of the Corporation (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Corporation for their action or consideration.
Preferred Stock, Shares Issued		1			0
Preferred Stock, Shares Outstanding		1			0
Series A Preferred Stock [Member] | Amendment To Series A Preferred [Member]
Preferred Stock, Convertible, Terms	On March 12, 2021, the Company amended the designation of the Special 2019 Series A Preferred shares and removed the right of the holder to convert the Special 2019 Series A Preferred share to 500,000,000 shares of common stock of the Company.
Series A Preferred Stock [Member] | Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues
Stock Issued During Period, Shares, Issued for Services
Stock Issued During Period, Value, Issued for Services
[custom:PreferredBSharesConvertedToCommonSharesShares]
[custom:PreferredBSharesConvertedToCommonSharesValue]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]
Preferred Class B [Member]
Preferred Stock, Shares Authorized		0			0
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001
Preferred Stock, Shares Issued		0			0
Preferred Stock, Shares Outstanding		0			0
Preferred Stock, Conversion Basis			Holders of the Series B Preferred Stock shall after two years of issuance, convert this Class B Preferred Stock based on each Class B Preferred Share equaling .00001% of the total issued and outstanding Common shares of the Company. In the event of a merger, reorganization, recapitalization or similar event of or with respect to the Corporation (other than a Corporate Change in which the Corporation is the surviving entity), this Class B Preferred Stock shall be converted based on each Class B Preferred Share equaling .00001% of the total issued and outstanding shares of common stock of the Company
Series B Preferred Stock [Member] | Preferred Stock [Member]
Conversion of Stock, Shares Converted					2
Conversion of Stock, Shares Issued					2,650
Conversion of Stock, Amount Converted					$ 6,000
Stock Issued During Period, Shares, New Issues
Stock Issued During Period, Shares, Issued for Services
Stock Issued During Period, Value, Issued for Services
[custom:PreferredBSharesConvertedToCommonSharesShares]				(2)
[custom:PreferredBSharesConvertedToCommonSharesValue]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized		2,000			2,000		2,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001
Preferred Stock, Shares Issued		503			0
Preferred Stock, Shares Outstanding		503			0
Preferred Stock, Value, Outstanding							$ 1,200
Preferred Stock, Dividend Rate, Percentage		8.00%
Debt Instrument, Convertible, Terms of Conversion Feature		Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock subject to Beneficial Ownership Limitations determined by dividing the Stated Value of $1,200 of such share by the Conversion Price
Series C Preferred Stock [Member] | Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues		503		503
Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage		75.00%
Stock Issued During Period, Shares, Issued for Services
Stock Issued During Period, Value, Issued for Services
[custom:PreferredBSharesConvertedToCommonSharesShares]
[custom:PreferredBSharesConvertedToCommonSharesValue]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]
Series C Preferred Stock [Member] | Redeemed Within 90 Days [Member]
Debt Instrument, Redemption, Description		If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days’ of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends.
Series C Preferred Stock [Member] | Redeemed After 90 Days [Member]
Debt Instrument, Redemption, Description		If all of the Series C Convertible Preferred Stock are redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends
Series C Preferred Stock [Member] | G H S [Member]
Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage		75.00%
Series C Preferred Stock [Member] | Tranche 1 [Member]
Stock Issued During Period, Shares, New Issues		300
Series C Preferred Stock [Member] | Commitment Shares [Member] | G H S [Member]
Stock Issued During Period, Shares, New Issues		35
Series C Preferred Stock [Member] | Commitment Shares [Member] | Proactive [Member]
Stock Issued During Period, Shares, New Issues		8
Series C Preferred Stock [Member] | Proactive [Member]
Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage		75.00%

NOTE 12 - COMMITMENTS AND CON_2

NOTE 12 - COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Mar. 25, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2022	Aug. 31, 2021
Operating Lease, Payments		$ 1,969	$ 3,045
[custom:InvestorRelationsAgreementTerm]	6 months
Saunders [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description		The Company has entered into an employment agreement with Steven Saunders, our Chief Commercial Officer and Director. The term is three years commencing July 1, 2021. Mr. Saunders is to receive monthly cash compensation of $15,000 reduced by $3,820 until at least $5,000,000 funding has been received through the S-1 offering. See Note 13 for a detail of employment terms amended subsequent to March 31, 2022.
Morris [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description				The Company entered into employment agreement with Stephen Morris, our Founder and Chief Technology Officer, the term is three years commencing July 1, 2021. Mr. Morris is to receive monthly cash compensation of $15,000 reduced by $4,790 until at least $5,000,000 has been received through the S-1 offering.
Willard [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description				The Company has entered into an employment agreement with Rik Willard to act as Chief Executive Officer of the company and as Director. The term is 1 year commencing August 15,2021. Mr. Willard is to receive monthly cash compensation of $15,000 reduced by $3,000 until at least $5,000,000 funding has been received through the S-1 offering. Mr. Willard was also granted a signing bonus of 102,040 restricted shares, which were issued in June 2021. See Note 13 for a detail of employment terms amended subsequent to March 31, 2022.
P C G Advisory [Member]
Payments to Suppliers		$ 7,000
Share-Based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost		$ 7,000
Scotland Premisis [Member]
Lessee, Operating Lease, Renewal Term			12 months
New Premisis [Member]
Lessee, Operating Lease, Renewal Term		12 months
Operating Lease, Cost		$ 600
New York Premisis [Member]
Operating Lease, Payments		600	$ 0
Lessee, Operating Lease, Renewal Term					12 months
Operating Lease, Cost		$ 200

NOTE 13 - SUBSEQUENT EVENTS (De

NOTE 13 - SUBSEQUENT EVENTS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Apr. 22, 2022	Mar. 04, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	1,413,804
Payments for Loans	$ (3,322)	$ (2,558)
Shareholder Loans Two [Member]
Debt Instrument, Face Amount					$ 81,162
Shareholder Loans Payment Two [Member]
Payments for Loans	$ 28,613
Tranche 2 [Member] | Series C Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues	200
G H S Tranche 2 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number			562,149
G H S [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	941,599
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value				$ 700,000
Preferred Stock, Shares Subscribed but Unissued				700